Novisibirsk

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• AstraZeneca2 trials

Running trials

• Active, not recruiting

  Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

  NCT04493853· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)

  NCT03521154· Phase 3· AstraZeneca· Source